| |
NYS Hepatitis B and C
Annual Report 2024
|
| |
| |
During 2024, newly reported chronic cases decreased by 13% while newly reported acute cases, which represent a recent infection, also decreased by 13% compared to 2023. More details can be found here:
https://www.health.ny.gov/statistics/diseases/communicable/docs/2024_hepatitis_b_c_annual_report.pdf
During 2024, 2,549 newly reported cases of hepatitis C were reported to the New York State Department of Health, including 2,362 chronic, 181 acute, and 6 perinatal cases. Chronic cases accounted for 93% of all newly reported cases, and acute cases for 7%. Perinatal reports accounted for less than 1% of all reports.
Baby Boomers represent.....24% of all newly reported cases while cases reported in persons under the age of 40 represent ..... (41%).
Effective May 3, 2024, New York State requires that all persons 18 years of age and older, and persons under the age of 18 with a risk, be offered a screening test for hepatitis C. Providers caring for pregnant people must order a hepatitis C screening test during each pregnancy. If the hepatitis C screening test is reactive, a hepatitis C RNA must be performed on the same specimen, or a second specimen collected at the same time as the initial hepatitis C screening test specimen, to confirm diagnosis of current infection. Individuals with a detectable hepatitis C RNA test must be offered follow-up hepatitis C health care and treatment or are
referred to a health care provider who can provide follow-up hepatitis C health care and treatment. Settings and clinicians required to make the offer include:
• Inpatient and emergency departments of an Article 28 licensed hospital.
• Outpatient departments of an Article 28 licensed hospital providing primary care services.
• Diagnostic and treatment centers licensed under article 28 providing primary care services.
• Physicians, physician assistants, nurse practitioners or midwives providing primary care.
| |
| |
| |
|
|
|
